BARBARA BROWDER: Open Payments
NPI 1740702901 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,305 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $161 |
| Vanda Pharmaceuticals Inc. | 5 | $157 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lundbeck LLC | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Corium, LLC | 3 | $46 |
| Alkermes, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, Auvelity, Azstarys, HETLIOZ, ARISTADA.
Industry payments across AZ — which companies pay providers there.
